Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits - Concepedia

Concepedia

Publication | Open Access

Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits

DOI Full Paper Access

133

Citations

21

References

2006

Year

Cheng-guang Yang, Ana M. González-Angulo, James M. Reuben, Daniel J. Booser, Lajos Pusztai, Savitri Krishnamurthy, Dixie Esseltine, James Stec, Kristine Broglio, R. Islam,

Annals of Oncology

Metastatic Breast CancerOncologyBiological EffectsBreast OncologyMedicineClinical BenefitsBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacology

References

	Year	Citations

Page 1

Page 1